Results 1 to 10 of about 6,412 (238)
Intratympanic corticosteroids in Ménière's disease: A mini-review [PDF]
Journal of Otology, 2017 This article reviews the effectiveness of intratympanic corticosteroids for vertigo control in Ménière's disease at 2-years follow-up according to the guidelines expressed by the American Academy of Otolaryngology-Head & Neck Surgery.
Mitesh Patel
doaj +9 more sources
Intratympanic Gentamicin Treatment for Ménière’s Disease [PDF]
, 2019 Ménière’s disease (MD) is an inner-ear disease mostly characterized by frequent spontaneous vertigo and fluctuating sensorineural hearing loss. The main purpose of treatment for MD is to reduce or control the vertigo while maximizing the preservation of ...
Yongchuan Chai, Hongzhe Li
core +6 more sources
Intratympanic corticosteroid for sudden hearing loss: does it really work? [PDF]
Brazilian Journal of Otorhinolaryngology, 2016 INTRODUCTION: Sudden deafness is characterized by an abrupt hearing loss of at least 30 dB in three sequential frequencies in the standard pure tone audiogram over three days or less.
Monique Antunes de Souza Chelminski Barreto +3 more
doaj +2 more sources
Intratympanic Therapies for Menière’s Disease [PDF]
Current Otorhinolaryngology Reports, 2014 There are multiple treatment options to consider when managing patients with Menière's disease. When conservative measures fail to control symptoms of Menière's disease, escalation of interventions may be required. Targeted drug delivery to the round window with intratympanic injections allows for local application of high concentrations of medications,
Matthew W. Miller, Yuri Agrawal
openalex +5 more sources
Cisplatin-Induced Ototoxicity: Effects, Mechanisms and Protection Strategies [PDF]
Toxics, 2015 Cisplatin is a highly effective chemotherapeutic agent that is widely used to treat solid organ malignancies. However, serious side effects have been associated with its use, such as bilateral, progressive, irreversible, dose-dependent neurosensory ...
Angela Callejo +3 more
doaj +2 more sources
Intratympanic treatment for tinnitus: A review
Noise and Health, 2013 Since the 1940s, various attempts have been made to treat peripheral tinnitus by way of intratympanic injection. This administration procedure requires only low concentrations of medication, thanks to the highly targeted delivery to the site of action ...
Thomas Meyer
doaj +4 more sources
Systemic effects of intratympanic dexamethasone therapy [PDF]
Endocrine Connections, 2014 ObjectiveThe study aimed to assess the possible systemic effects of intratympanic dexamethasone (IT-Dex) on the hypothalamic–pituitary–adrenal (HPA) axis, inflammation, and bone metabolism.DesignA prospective cohort study including 30 adult patients of a tertiary referral ENT clinic treated with 9.6 mg IT-Dex over a period of 10 days was carried out ...
Eva Nóvoa +2 more
openalex +3 more sources
Intratympanic Steroid for Menière's Disease: A Systematic Review [PDF]
Otology & Neurotology, 2019 Objectives: To investigate the beneficial effects and safety of intratympanic steroid installation compared with placebo in patients with Menière's disease. Methods: We performed a systematic literature search in MEDLINE and EMBASE for existing systematic reviews and individual ...
Louise Devantier +6 more
openalex +7 more sources
Intratympanic Drug Delivery for Tinnitus Treatment [PDF]
, 2017 Objective: The aim of the study to evaluate the effectiveness of oral and injection intratympanic methylprednisolone to treat acute tinnitus associated with idiopathic sudden sensorineural hearing ...
Monique Antunes de Souza Chelminski Barreto +3 more
openalex +4 more sources
A Case of Binocular Vertical Diplopia after Intratympanic Gentamicin Therapy
European Journal of Case Reports in Internal Medicine, 2019 Intratympanic gentamicin therapy is a useful alternative treatment for refractory Meniere's disease and is generally well tolerated. Visual disturbances as side effects of this treatment are rarely reported in the literature.
Giacomo Cioffi +4 more
doaj +3 more sources